AstraZeneca stock jumps as COPD drug trial win surprises market

AstraZeneca stock jumps as COPD drug trial win surprises market AstraZeneca stock jumps as COPD drug trial win surprises market Health & pharma AI Sentiment: 82/100 Bullish This score is generated through AI-driven analysis of the article's content. Author Ananthu C U Mar 27, 2026, 14:55 PM Shares of AstraZeneca rose on Friday after the drugmaker reported positive results from late-stage clinical trials of its experimental chronic obstructive pulmonary disease (COPD) treatment, tozorakimab. The UK-based pha ...